Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2009 1
2010 2
2011 2
2012 3
2013 3
2014 2
2015 2
2016 1
2017 5
2018 5
2019 6
2020 11
2021 9
2022 8
2023 7
2024 6
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Peled JU, et al. Among authors: gyurkocza b. N Engl J Med. 2020 Feb 27;382(9):822-834. doi: 10.1056/NEJMoa1900623. N Engl J Med. 2020. PMID: 32101664 Free PMC article.
Tolerance and chimerism.
Kolb HJ, Guenther W, Gyurkocza B, Hoetzl F, Simoes B, Falk C, Schleuning M, Ledderose G. Kolb HJ, et al. Among authors: gyurkocza b. Transplantation. 2003 May 15;75(9 Suppl):26S-31S. doi: 10.1097/01.TP.0000067948.90241.82. Transplantation. 2003. PMID: 12819487 Review.
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.
Nguyen CL, Markey KA, Miltiadous O, Dai A, Waters N, Sadeghi K, Fei T, Shouval R, Taylor BP, Liao C, Slingerland JB, Slingerland AE, Clurman AG, Maloy MA, Bohannon L, Giardina PA, Brereton DG, Armijo GK, Fontana E, Gradissimo A, Gyurkocza B, Sung AD, Chao NJ, Devlin SM, Taur Y, Giralt SA, Perales MA, Xavier JB, Pamer EG, Peled JU, Gomes ALC, van den Brink MRM. Nguyen CL, et al. Among authors: gyurkocza b. Cell. 2023 Jun 8;186(12):2705-2718.e17. doi: 10.1016/j.cell.2023.05.007. Epub 2023 Jun 8. Cell. 2023. PMID: 37295406 Free PMC article.
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant.
DeWolf S, Kuttiyara J, Vinci P, Fei T, Slingerland J, Katsamakis Z, Fein JA, Gipson B, Lorenc R, Zinsmeyer V, Marcello L, Giardina P, Donohoe W, Shah G, Lin R, Papadopoulos E, Gyurkocza B, Shaffer B, Tallman M, Politikos I, Giralt SA, Barker J, Perales MA, Tamari R, Abdel-Wahab O, Cho C, Hsu K, Peled JU, van den Brink MRM, Hanash AM. DeWolf S, et al. Among authors: gyurkocza b. Blood Adv. 2025 Oct 28;9(20):5274-5282. doi: 10.1182/bloodadvances.2024015626. Blood Adv. 2025. PMID: 40505068 Free PMC article.
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Gyurkocza B, Nath R, Seropian S, Choe H, Litzow MR, Abboud C, Koshy N, Stiff P, Tomlinson B, Abhyankar S, Foran J, Hari P, Chen G, Al-Kadhimi Z, Kebriaei P, Sabloff M, Orozco JJ, Jamieson K, Silverman M, Van Besien K, Schuster M, Law AD, Larkin K, Pandit-Taskar N, Rowley SD, Munshi P, Cook R, Levy MY, Lazarus HM, Sandmaier BM, Pagel JM, Reddy V, MacDougall J, McNamara K, Spross J, Haeuber E, Vusirikala M, Nahar A, Desai A, Giralt S. Gyurkocza B, et al. J Clin Oncol. 2025 Jan 10;43(2):201-213. doi: 10.1200/JCO.23.02018. Epub 2024 Sep 19. J Clin Oncol. 2025. PMID: 39298738 Free PMC article. Clinical Trial.
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation.
Politikos I, Brown S, Fein JA, Eng S, Casem K, Chinapen S, Quach S, Scaradavou A, Cho C, Dahi P, Giralt SA, Gyurkocza B, Hanash AM, Jakubowski AA, Papadopoulos EB, Perales MA, Ponce DM, Shaffer BC, Tamari R, Young JW, Devlin S, Peled JU, Barker JN. Politikos I, et al. Among authors: gyurkocza b. Blood Adv. 2025 May 27;9(10):2570-2584. doi: 10.1182/bloodadvances.2024014177. Blood Adv. 2025. PMID: 40423982 Free PMC article. Clinical Trial.
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 study.
Scordo M, Perales MA, Mauguen A, Lin A, Kunvarjee B, Paes Pena M, Mcavoy D, Nguyen LK, Hogan M, Chapman N, Bieler J, Cho C, Gyurkocza B, Harris AC, Spitzer B, O'Reilly RJ, Jakubowski AA, Lin RJ, Papadopoulos EB, Politikos I, Ponce DM, Shaffer BC, Shah GL, Tamari R, Giralt SA, Boelens JJ, Curran KJ. Scordo M, et al. Among authors: gyurkocza b. Lancet Haematol. 2025 Dec;12(12):e956-e965. doi: 10.1016/S2352-3026(25)00293-5. Lancet Haematol. 2025. PMID: 41338864 Clinical Trial.
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation Recipients.
Han G, Stern A, Lee YJ, Li Y, Dahi PB, Tamari R, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Shaffer B, Perales MA, Obeid KM, Young JH, Papanicolaou GA. Han G, et al. Among authors: gyurkocza b. Transplant Cell Ther. 2025 Feb;31(2):105.e1-105.e9. doi: 10.1016/j.jtct.2024.12.010. Epub 2024 Dec 17. Transplant Cell Ther. 2025. PMID: 39701288 Free PMC article.
72 results